Health Canada approval last week of multiple sclerosis drug ‘absolutely a game-changer’

Global News - Joseph Petrilli said he cried for a long time when he heard that Health Canada approved a new drug that could...

Mallinckrodt Acthar Gel phase IV clinical study with relapsing multiple sclerosis

STAINES-UPON-THAMES, United Kingdom Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4...

Celgene announces data on its phase III relapsing MS Ozanimod experimental treatment

Study met the primary endpoint of annualized relapse rate (ARR) and key secondary MRI endpoints of T2 and GdE lesions, compared to interferon (IFN)...

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody...

Market access restrictions for high efficacy Multiple Sclerosis therapies may be hindering their ability to optimally treat their clinically complex, relapsing patients, according to...
video

Cladridbine for the Treatment of Multiple Sclerosis

Dr. Daniel Kantor speaks with Dr. Kottil Rammohan, Professor of Neurology at University of Miami and Director of the MS Center about Cladribine for...

Biogen, AbbVie yank multiple sclerosis drug Zinbryta off global market

Zinbryta (daizumab) was flagged by European regulators with a lethal safety warning over cases of encephalitis and meningoencephalitis. Evaluating the drug's "complex and evolving...

Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS

SOURCE Novartis- Breakthrough Therapy designation can expedite the development and review of therapies for serious conditions- In a pivotal Phase III study, oral fingolimod...
video

University of Calgary research using acne medication to combat MS

A Canadian clinical trial led by researchers at the University of Calgary's Hotchkiss Brain Institute (HBI), at the Cumming School of Medicine (CSM), shows...

Multiple sclerosis ”game changer” drug gets government subsidy in Australia

Melanie Row was enjoying a family holiday on the Gold Coast in 2016 when she noticed she didn't have control of her right thumb.The...

Multiple Sclerosis: Are we close to a cure?

Hannah Nichols recently posed this question in Medical News Today, "Researchers are uncovering many potential treatment routes for MS. Could they be close to...

Social Media

746FollowersFollow